Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers

Objective Given the lack of clarity on the expression status of SRC1 protein in breast cancer, we attempted to ascertain the clinical implications of the expression of this protein in breast cancer.